Genoskin propose des alternatives high-tech aux essais sur les animaux et révolutionne le développ
Location: France
Employees: 11-50
Total raised: $8.7M
Founded date: 2011
Investors 2
| Date | Name | Website |
| 18.07.2022 | North Shor... | nsiv.org |
| 03.11.2025 | Grand Sud ... | gsocapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.09.2025 | Series A | $8.7M | Caisse d'E... |
Mentions in press and media 3
| Date | Title | Description |
| 16.09.2025 | Genoskin Raises $8.7M in Series A Funding | Genoskin, a Toulouse, France-based contract research organization (CRO) developing ex vivo human skin platforms, raised $8.7M in Series A funding. The round consisted of an equity investment of $5.4M led by OCCTE (FPCI Occidev Impacts), alo... |
| 16.09.2025 | Genoskin raises $8.7M to advance human skin models as animal testing alternative | Genoskin, a Contract Research Organisation (CRO) developing ex vivo human skin platforms capable of testing injected drugs and implanted medical devices, today announces it has raised $8.7 million in its first funding round. Genoskin provid... |
| - | Genoskin | “Genoskin's technology maintains ex vivo human skin models alive and functional for at least 7 days. Let's accelerate science together!” |